Skip to content

Post-surgical Aortic Hemodynamics After Aortic Valve Replacement

Investigation of Post-surgical Aortic Hemodynamics After Aortic Valve Replacement

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03347851
Enrollment
20
Registered
2017-11-20
Start date
2017-10-26
Completion date
2020-06-01
Last updated
2021-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Valve Heart Disease

Keywords

mechanical heart valve, On-X

Brief summary

The purpose of this pilot study is to obtain both near valve and downstream flow characteristics, using 3D transthoracic echocardiography and 4D flow MRI respectively, in an existing patient population at Northwestern Memorial Hospital, to determine the hinge washout characteristics and downstream flow patterns of the On-X valve and compared to competing designs.

Detailed description

Prospective, concurrent 4D flow Magnetic Resonance Imaging (MRI) and echocardiography of On-X and St Jude Medical (SJM) Masters HP or Carbomedics Carbo-seal or Carbo-seal Valsalva aortic valve replacement (AVR) patients will be performed. Echocardiography analysis will include: valve function (opening angle), pressure gradients, and degree of valve washout. MRI analysis will focus on downstream flow patterns (helicity and vorticity), energy loss, pressure recovery, and measurement of wall shear stress in the anastomosis regions.

Interventions

OTHERMRI

Enrolled patients will complete a non-contrast cardiac MRI

OTHERTransthoracic echocardiography exam

Enrolled patients will complete a transthoracic echocardiography exam.

Sponsors

Northwestern University
CollaboratorOTHER
CryoLife, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No

Inclusion criteria

* Male and female subjects 18-89 years of age * Patients with aortic valve disease who within the last five years underwent AVR using the On-X aortic valve, SJM Masters HP, or Carbomedics aortic valves.

Exclusion criteria

* Patients contraindicated against MRI * Patients with pacemakers, cochlear (in the ear) implants, or aneurysm clips or patients who have worked with metal * Patients unwilling or unable to give written informed consent * Pregnant women * Prisoners * Patients with an Effective Orifice Area index (EOAi) \<0.85 cm2/m2

Design outcomes

Primary

MeasureTime frameDescription
Downstream flow patterns (helicity and vorticity)3 monthsMRI data analysis; Helicity and vorticity graded (1-3) by blinded reviewers.
Hinge washout3 monthsMRI data analysis; Yes/No
Energy loss3 monthsMRI data analysis; Irreversible energy loss quantified.Efforts will include the quantification of turbulent kinetic energy. This is representative of permanent pressure loss.
Wall shear stress (WSS)3 monthsMRI data analysis; WSS, the tangential force exerted by blood flow on the vessel wall, measured in the anastomosis regions

Secondary

MeasureTime frameDescription
Normalized ESV (mL/m^2)3 monthsEnd Systolic Volume
Peak Velocity (m/s)3 months
Mean velocity (m/s)3 months
Ejection Fraction (%)3 months
Mean transvalvular pressure gradient (mmHg)3 months
Effective Orifice Area (EOA)3 months
Effective Orifice Area index (EOAi)3 months
Peak transvalvular pressure gradient (mmHg)3 months
Primary EDV (ml)3 monthsEnd Diastolic Volume
Normalized EDV (ml/m^2)3 monthsEnd Diastolic Volume
Primary ESV (mL)3 monthsEnd Systolic Volume

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026